Parasite killer Ivermectin stops cancer drug resistance 24 November 2019
A widely available insecticide, Ivermectin, has been shown to make drug-resistant tumours and leukaemia immediately responsive to the drugs; this is not the first time anti-cancer activity has been shown, with previous research on breast, ovarian, lymphoma and TNBC, plus studies showing improved response to Adriamycin and Taxol.
A Doctor put my friend's father, who suffers from lung cancer, on Hydroxychloroquine and he's been doing great since then.